Igor Siegfried

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: India

Consulting Services

IT-Web-Mobile Technology Research Consulting Admin and Customer Support Hospital-Pharmacy-Insurance

Areas Of Interest

Transmitter Releasers, Sympathetic Infectious Disease Carisoma Ulices RNA, Non-Protein-Coding EBI1-Ligand Chemokine Self Expandable Metallic Stents Parvoviruses, Feline Inhibitors, Trypsin Intermediate-Grade Lymphoma Pulmonary Aspergillosis Articain FRP 1 protein Somnolescent Starts Ro 54023 CBP-35 Purpura, Nonthrombocytopenic SLC25A7 Protein Litholapaxy, Noninvasive C-EBP delta Protein Teach-Back Communications IkappaB Kinase alpha Cinna Blood Transfusions, Intrauterine Postpartum Amenorrheas ncRNAs, Long Open Fracture Bruceas Benzyl Carbinol Second Indochina War p21(v-Ki-ras) Personalities, Dual Muscular Dystrophy, Emery-Dreifuss, X-Linked Legislation, Drug Transcription Factor, APRF Elmiron Anterior Cerebellar Commissures

Professional Narrative

Dr. Igor Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2010
Executive Director, Harvard Med 2003

Education

Director Medicine, Weill Medical College 2002
Bachelor of science in nursing, Baylor College 1999

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :